April 23rd, 2008
(Photo: Breast cancer cell , courtesy www.hopeforcancer.com)
Scientists believe they have identified a gene that may be able to limit the growth of breast cancer tumors.
The US National Cancer Institute, led by geneticist Kent Hunter found in tests on mice that tumors containing the bromodomain 4 or Brd4 gene ended up 10 times smaller than ones that did […]
By Elaine -- 0 comments
April 22nd, 2008
KQED Public Broadcasting in San Francisco recently did a radio story about the UC San Francisco Canine Behavioral Genetics Project run in collaboration with the University of Pennsylvania. The aims of the project are:
1. To explore the relationship between genes and behavior, both normal and abnormal, in domestic dogs.
2. To assess the amount and nature […]
By Elaine -- 1 comment
April 20th, 2008
MRI of a migraine
Migraine is the most common cause of episodic headache, and by far the most common neurological cause of a doctor’s visit. It affects some 15% of the world’s population.
Researchers from Helsinki University, Finland and the Sanger Institute, UK were able for the first time to convincingly demonstrate a genomic locus to be linked to […]
By Elaine -- 0 comments
April 14th, 2008
The Washington Post featured a series of thought-provoking articles in ‘The Science Century’ section of the newspaper.
Here are some of my favourites:
The Post’s Joel Achenbach writes about how “the most important things
happening in the world today…[will] be happening in laboratories — out
of sight, inscrutable and unhyped until the very moment when they change
life as we […]
By Elaine -- 2 comments
April 12th, 2008
G&H’s INTERVIEW WITH NAVIGENICS
Navigenics approached Genetics and Health for an interview. With so much written about similar genomics companies such as 23andme, Knome, deCODE genetics, I was intrigued to learn more about this company. In particular, Navigenics appears to be the only company within this industry genre who provides a comprehensive wellness model – a […]
By Elaine -- 3 comments
April 11th, 2008
Concluding G&H’s exclusive interview with Navigenics’ Medical Director Dr Michael Nierenberg, we explore the challenges faced by Navigenics to integrate its genomic services into mainstream medicine …
When founding my old company Opaldia, probably the single most challenging aspect of early adoption of genetic testing was physician barriers. Mostly this was borne out of a genuine lack of understanding […]
By Elaine -- 0 comments
April 9th, 2008
In this fourth in the series of articles originating from G&H’s exlusive interview with Navigenics’ Medical Director Dr Michael Nierenberg, we look at the whole issue of low penetrance versus high penetrance gene testing.
SNPs are known as ‘low penetrance genes’ where it will only sometimes produce the symptom or trait with which it has been associated […]
By Elaine -- 1 comment
April 9th, 2008
In this third article originating from G&H’s exclusive interview with Navigenics’ Medical Director, Dr Michael Nierenberg, we explore the whole issue of SNP testing and how SNPs can be used in disease risk assessment.
Navigenics has focused on around 100 of the most definitive research papers on SNPs (single nucleotide polymorphisms) that have been most strongly associated […]
By Elaine -- 2 comments
April 7th, 2008
This is the first article originating from G&H’s exclusive interview with Navigenics’ Medical Director Dr Michael Nierenberg. We take a look at the company and who is behind Navigenics.
The much anticipated launch!
April 8th, 2008 Navigenics Inc launches its genomics service In New York.
It has branded its service as “Navigenics Health Compass”.
In its launch literature the […]
By Elaine -- 2 comments
April 7th, 2008
Navigenics approached Genetics and Health for an interview. With so much written about similar genomics companies such as 23andme, Knome, deCODE genetics, I was intrigued to learn more about this company. In particular, Navigenics appears to be the only company within this industry genre who provides a comprehensive wellness model – a healthcare model that […]
By Elaine -- 1 comment
Recent Comments